Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Κατάταξη σε μετοχές #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Τιμή μετοχής
$5.52
Τελευταίος συγχρονισμός: 2025-10-09
Κεφαλαιοποίηση
$775.10M
Αλλαγή (1 ημέρα)
1.28%
Αλλαγή (1 έτος)
15.48%
Χώρα
US
Εμπόριο BioSig Technologies, Inc. (BSGM)

Κατηγορία

Κέρδη για την BioSig Technologies, Inc. (BSGM)
Κέρδη τον Sep 2025 TTM: $-40.62M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της BioSig Technologies, Inc., τα τρέχοντα κέρδη της εταιρείας είναι $-40.62M. Το 2023, η εταιρεία παρουσίασε κέρδη $-28.69M, μείωση σε σύγκριση με των κερδών του 2022 που ήταν $-27.26M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την BioSig Technologies, Inc. από 2011 έως 2026
Κέρδη στο τέλος κάθε έτους
Έτος Κέρδη Αλλαγή
2026 (TTM) $-40.62M 292.84%
2024 $-10.34M -63.96%
2023 $-28.69M 5.24%
2022 $-27.26M -17.03%
2021 $-32.86M -44.44%
2020 $-59.14M 71.57%
2019 $-34.47M 99.81%
2018 $-17.25M 35.88%
2017 $-12.70M 9.57%
2016 $-11.59M 22.47%
2015 $-9.46M 11.67%
2014 $-8.47M -13.58%
2013 $-9.80M 310.90%
2012 $-2.39M 107.27%
2011 $-1.15M 0.00%
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
Εταιρεία Κέρδη Διαφορά Κερδών Χώρα
$7.51B -18,592.71%
US
$5.15B -12,774.81%
US
$5.56B -13,796.57%
IE
$3.86B -9,606.11%
US
- -
DE